CL logo

Colgate-Palmolive (CL) Cash and cash equivalents

annual cash & cash equivalents:

$1.10B+$130.00M(+13.46%)
December 31, 2024

Summary

  • As of today (June 23, 2025), CL annual cash & cash equivalents is $1.10 billion, with the most recent change of +$130.00 million (+13.46%) on December 31, 2024.
  • During the last 3 years, CL annual cash & cash equivalents has risen by +$264.00 million (+31.73%).
  • CL annual cash & cash equivalents is now -28.60% below its all-time high of $1.53 billion, reached on December 31, 2017.

Performance

CL Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLbalance sheet metrics

quarterly cash & cash equivalents:

$1.11B+$16.00M(+1.46%)
March 31, 2025

Summary

  • As of today (June 23, 2025), CL quarterly cash & cash equivalents is $1.11 billion, with the most recent change of +$16.00 million (+1.46%) on March 31, 2025.
  • Over the past year, CL quarterly cash & cash equivalents has increased by +$33.00 million (+3.06%).
  • CL quarterly cash & cash equivalents is now -38.05% below its all-time high of $1.79 billion, reached on March 31, 2014.

Performance

CL quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

CL Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+13.5%+3.1%
3 y3 years+31.7%+26.8%
5 y5 years+24.1%+30.2%

CL Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+41.4%-9.9%+43.5%
5 y5-yearat high+41.4%-9.9%+43.5%
alltimeall time-28.6%+1819.4%-38.0%+1847.5%

CL Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$1.11B(+1.5%)
Dec 2024
$1.10B(+13.5%)
$1.10B(-11.2%)
Sep 2024
-
$1.23B(+11.2%)
Jun 2024
-
$1.11B(+2.9%)
Mar 2024
-
$1.08B(+11.7%)
Dec 2023
$966.00M(+24.6%)
$966.00M(+1.6%)
Sep 2023
-
$951.00M(+16.1%)
Jun 2023
-
$819.00M(-5.5%)
Mar 2023
-
$867.00M(+11.9%)
Dec 2022
$775.00M(-6.9%)
$775.00M(-17.4%)
Sep 2022
-
$938.00M(+9.3%)
Jun 2022
-
$858.00M(-2.2%)
Mar 2022
-
$877.00M(+5.4%)
Dec 2021
$832.00M(-6.3%)
$832.00M(-13.2%)
Sep 2021
-
$958.00M(+2.2%)
Jun 2021
-
$937.00M(-5.8%)
Mar 2021
-
$995.00M(+12.0%)
Dec 2020
$888.00M(+0.6%)
$888.00M(-10.2%)
Sep 2020
-
$989.00M(-0.8%)
Jun 2020
-
$997.00M(+16.7%)
Mar 2020
-
$854.00M(-3.3%)
Dec 2019
$883.00M(+21.6%)
$883.00M(-6.9%)
Sep 2019
-
$948.00M(+9.8%)
Jun 2019
-
$863.00M(+2.4%)
Mar 2019
-
$843.00M(+16.1%)
Dec 2018
$726.00M(-52.7%)
$726.00M(-13.7%)
Sep 2018
-
$841.00M(+1.0%)
Jun 2018
-
$833.00M(-2.1%)
Mar 2018
-
$851.00M(-44.6%)
Dec 2017
$1.53B(+16.7%)
$1.53B(+11.2%)
Sep 2017
-
$1.38B(+11.2%)
Jun 2017
-
$1.24B(-7.9%)
Mar 2017
-
$1.35B(+2.4%)
Dec 2016
$1.31B(+35.6%)
$1.31B(+1.3%)
Sep 2016
-
$1.30B(+19.6%)
Jun 2016
-
$1.08B(+7.0%)
Mar 2016
-
$1.01B(+4.5%)
Dec 2015
$970.00M(-10.9%)
$970.00M(-32.9%)
Sep 2015
-
$1.45B(+36.4%)
Jun 2015
-
$1.06B(+23.3%)
Mar 2015
-
$859.00M(-21.1%)
Dec 2014
$1.09B(+13.2%)
$1.09B(-19.6%)
Sep 2014
-
$1.35B(+16.7%)
Jun 2014
-
$1.16B(-35.3%)
Mar 2014
-
$1.79B(+86.6%)
Dec 2013
$962.00M(+8.8%)
$962.00M(+33.4%)
Sep 2013
-
$721.00M(-18.4%)
Jun 2013
-
$884.00M(-5.2%)
Mar 2013
-
$932.00M(+5.4%)
Dec 2012
$884.00M(+0.7%)
$884.00M(-2.8%)
Sep 2012
-
$909.00M(-8.6%)
Jun 2012
-
$995.00M(-4.7%)
Mar 2012
-
$1.04B(+18.9%)
Dec 2011
$878.00M(+79.2%)
$878.00M(-7.1%)
Sep 2011
-
$945.00M(+27.9%)
Jun 2011
-
$739.00M(+7.7%)
Mar 2011
-
$686.00M(+40.0%)
Dec 2010
$490.00M(-18.3%)
$490.00M(-12.7%)
Mar 2010
-
$561.00M(-6.5%)
Dec 2009
$600.00M(+8.1%)
$600.00M(-29.2%)
Sep 2009
-
$847.00M(-5.5%)
Jun 2009
-
$896.00M(+27.6%)
Mar 2009
-
$702.20M(+26.5%)
Dec 2008
$555.00M(+29.5%)
$555.00M(-12.6%)
Sep 2008
-
$634.70M(+1.9%)
Jun 2008
-
$622.80M(-3.0%)
Mar 2008
-
$642.10M(+49.8%)
Dec 2007
$428.70M(-12.4%)
$428.70M(-31.8%)
Sep 2007
-
$628.40M(+14.9%)
Jun 2007
-
$546.90M(+15.3%)
Mar 2007
-
$474.40M(-3.1%)
Dec 2006
$489.50M
$489.50M(-2.7%)
Sep 2006
-
$502.90M(+16.8%)
DateAnnualQuarterly
Jun 2006
-
$430.40M(+12.4%)
Mar 2006
-
$382.80M(+12.4%)
Dec 2005
$340.70M(+6.6%)
$340.70M(-9.5%)
Sep 2005
-
$376.30M(-4.0%)
Jun 2005
-
$392.10M(-5.3%)
Mar 2005
-
$413.90M(+29.5%)
Dec 2004
$319.60M(+20.5%)
$319.60M(-13.8%)
Sep 2004
-
$370.60M(-11.2%)
Jun 2004
-
$417.30M(+53.7%)
Mar 2004
-
$271.50M(+2.3%)
Dec 2003
$265.30M(+58.0%)
$265.30M(+3.6%)
Sep 2003
-
$256.10M(+16.8%)
Jun 2003
-
$219.20M(+6.5%)
Mar 2003
-
$205.80M(+22.6%)
Dec 2002
$167.90M(-2.8%)
$167.90M(-16.3%)
Sep 2002
-
$200.70M(-18.9%)
Jun 2002
-
$247.40M(+33.9%)
Mar 2002
-
$184.80M(+7.0%)
Dec 2001
$172.70M(-16.4%)
$172.70M(-40.4%)
Sep 2001
-
$289.60M(+15.3%)
Jun 2001
-
$251.10M(+10.2%)
Mar 2001
-
$227.90M(+10.3%)
Dec 2000
$206.60M(+3.5%)
$206.60M(-2.0%)
Sep 2000
-
$210.90M(-5.9%)
Jun 2000
-
$224.20M(+8.6%)
Mar 2000
-
$206.40M(+3.4%)
Dec 1999
$199.60M(+9.9%)
$199.60M(-24.0%)
Sep 1999
-
$262.50M(+32.5%)
Jun 1999
-
$198.10M(+4.8%)
Mar 1999
-
$189.00M(+4.0%)
Dec 1998
$181.70M(-0.8%)
$181.70M(-13.5%)
Sep 1998
-
$210.00M(+19.3%)
Jun 1998
-
$176.10M(-0.1%)
Mar 1998
-
$176.20M(-3.8%)
Dec 1997
$183.10M(-26.2%)
$183.10M(-19.5%)
Sep 1997
-
$227.40M(-2.9%)
Jun 1997
-
$234.30M(+40.0%)
Mar 1997
-
$167.30M(-32.6%)
Dec 1996
$248.20M(+18.9%)
$248.20M(+11.5%)
Sep 1996
-
$222.70M(+17.3%)
Jun 1996
-
$189.80M(-8.3%)
Mar 1996
-
$206.90M(-0.9%)
Dec 1995
$208.80M(+22.9%)
$208.80M(-6.8%)
Sep 1995
-
$224.00M(+35.4%)
Jun 1995
-
$165.40M(-3.6%)
Mar 1995
-
$171.50M(+0.9%)
Dec 1994
$169.90M(+17.9%)
$169.90M(-6.1%)
Sep 1994
-
$180.90M(+18.6%)
Jun 1994
-
$152.50M(+3.1%)
Mar 1994
-
$147.90M(+2.6%)
Dec 1993
$144.10M(+22.2%)
$144.10M(-15.4%)
Sep 1993
-
$170.30M(+12.8%)
Jun 1993
-
$151.00M(-14.1%)
Mar 1993
-
$175.70M(+49.0%)
Dec 1992
$117.90M(-30.0%)
$117.90M(-30.9%)
Sep 1992
-
$170.50M(+0.2%)
Jun 1992
-
$170.20M(-16.0%)
Mar 1992
-
$202.60M(+20.2%)
Dec 1991
$168.50M(+1.3%)
$168.50M(+31.1%)
Sep 1991
-
$128.50M(+2.4%)
Jun 1991
-
$125.50M(-5.4%)
Mar 1991
-
$132.70M(-20.3%)
Dec 1990
$166.40M(-58.2%)
$166.40M(+30.6%)
Sep 1990
-
$127.40M(-30.4%)
Jun 1990
-
$183.10M(-23.3%)
Mar 1990
-
$238.70M(-40.0%)
Dec 1989
$397.90M(+8.9%)
$397.90M(+86.6%)
Sep 1989
-
$213.20M(-41.7%)
Dec 1988
$365.50M(+540.1%)
$365.50M(+540.1%)
Dec 1987
$57.10M(-65.4%)
$57.10M(-65.4%)
Dec 1986
$165.10M(-36.4%)
$165.10M(-36.4%)
Dec 1985
$259.50M(-26.2%)
$259.50M(-26.2%)
Dec 1984
$351.70M
$351.70M

FAQ

  • What is Colgate-Palmolive annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Colgate-Palmolive?
  • What is Colgate-Palmolive annual cash & cash equivalents year-on-year change?
  • What is Colgate-Palmolive quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Colgate-Palmolive?
  • What is Colgate-Palmolive quarterly cash & cash equivalents year-on-year change?

What is Colgate-Palmolive annual cash & cash equivalents?

The current annual cash & cash equivalents of CL is $1.10B

What is the all time high annual cash & cash equivalents for Colgate-Palmolive?

Colgate-Palmolive all-time high annual cash & cash equivalents is $1.53B

What is Colgate-Palmolive annual cash & cash equivalents year-on-year change?

Over the past year, CL annual cash & cash equivalents has changed by +$130.00M (+13.46%)

What is Colgate-Palmolive quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of CL is $1.11B

What is the all time high quarterly cash & cash equivalents for Colgate-Palmolive?

Colgate-Palmolive all-time high quarterly cash & cash equivalents is $1.79B

What is Colgate-Palmolive quarterly cash & cash equivalents year-on-year change?

Over the past year, CL quarterly cash & cash equivalents has changed by +$33.00M (+3.06%)
On this page